Search
News
PRA Group Q2 2026 Earnings: European ERC Review Lifts Revenue and Profit
PRA Group’s Q2 2026 revenue increased 29% year over year to $372.2 million, while GAAP diluted EPS rose to $1.51 from $1.08. Total cash collections grew 4% to $558.5 million, a much slower pace than reported revenue, because a comprehensive European portfolio review increased ERC by approximately $349 million and lifted changes in expected recoveries. Operating expenses rose 8% to $218.9 million, mainly due to higher legal collection costs, while net income attributable to PRA Group reached $57.9 million. Investors should monitor whether revised European recovery forecasts convert into sustained collections.
TradingKey
Thu, Aug 6
Rocket Companies Q2 2026 earnings: Revenue nearly doubles as mortgage profitability expands
Rocket Companies (NYSE: RKT) reported Q2 2026 net revenue of $2.78 billion, up from $1.45 billion a year earlier, while GAAP diluted EPS improved to $0.08 from a $0.01 loss. Adjusted EBITDA rose to $766 million, and Mortgage contribution margin reached $1.17 billion as purchase and refinance market share hit record quarterly levels. Total liquidity stood at $11.2 billion after $53 billion of MSR sales generated $795 million in cash proceeds. Rocket guided Q3 adjusted revenue to $2.5 billion-$2.7 billion, below Q2’s level.
TradingKey
Thu, Aug 6
Lionsgate Fiscal Q1 2027 Earnings: Motion Picture Revenue More Than Doubles
Lionsgate Studios’ fiscal Q1 2027 revenue rose 48% year over year to $776.6 million, while diluted loss per share from continuing operations improved to $0.10 from $0.35. Motion Picture revenue more than doubled to $587.3 million and segment profit reached $105.0 million, offsetting lower Television Production results. Operating cash flow from continuing operations turned positive at $54.1 million, and adjusted free cash flow was $128.9 million. The quarter still ended with a $28.8 million attributable continuing-operations net loss as interest expense and elevated share-based compensation weighed on GAAP results.
TradingKey
Thu, Aug 6
Shoulder Innovations Q2 2026 earnings: 56% revenue growth lifts the outlook
Shoulder Innovations (NYSE: SI) reported Q2 2026 revenue of $17.2 million, up 56%, as implant system volume increased about 50% and average selling price rose 5% to $7,674. Gross margin improved to 78.3% from 76.2%, but operating loss widened to $10.0 million as SG&A and R&D spending increased. The company raised full-year 2026 revenue guidance to $67 million-$69 million, while cash and marketable securities totaled $99.0 million. Investors now need to assess whether commercial expansion can produce better operating leverage.
TradingKey
Thu, Aug 6
Genpact Q2 2026 Earnings: Advanced Technology Solutions Drives Growth
Genpact’s Q2 2026 net revenue rose 7.1% year over year to $1.343 billion, while diluted EPS increased 14.7% to $0.86. Advanced Technology Solutions revenue grew 24.1% to $363 million and supplied most of the company’s incremental revenue, offsetting slower 1.9% growth in Core Business Services. Gross margin reached 36.5%, but quarterly operating cash flow fell to $72 million from $177 million. Genpact raised its full-year Advanced Technology Solutions growth outlook to at least 25% and adjusted diluted EPS growth guidance to at least 12%.
TradingKey
Thu, Aug 6
Amphastar Q2 2026 Earnings: New Products Lift Revenue and Gross Margin
Amphastar Pharmaceuticals’ Q2 2026 revenue rose 5% to $183.9 million, while GAAP diluted EPS increased to $0.67 from $0.64. Gross margin expanded 120 basis points to 50.8% as higher-margin launches offset pricing pressure in BAQSIMI and glucagon. Operating income declined to $39.7 million as selling, administrative, and R&D expenses increased. Six-month operating cash flow was $99.2 million, while a $100 million BAQSIMI milestone payment to Eli Lilly is due in Q3 2026.
TradingKey
Thu, Aug 6
CleanSpark Fiscal Q3 2026 Earnings: Bitcoin Valuation Losses Drive a $239.8 Million Net Loss
CleanSpark’s fiscal Q3 2026 revenue fell 30.5% year over year to $138.0 million, while diluted EPS swung to a loss of $0.89 from income of $0.78. The company recorded a $239.8 million net loss and negative adjusted EBITDA of $113.0 million, with a $116.3 million fair-value loss on bitcoin and weaker mining economics weighing on results. CleanSpark ended June 30 with $202.6 million in cash, $814.9 million in bitcoin holdings and related collateral assets, and $1.8 billion in long-term debt as it advanced the Sandersville data center lease.
TradingKey
Thu, Aug 6
ICF Q2 2026 Earnings: Margins Hold as Federal Revenue Declines
ICF’s Q2 2026 revenue was $474.5 million, down about 0.4% year over year, while GAAP diluted EPS increased 16.4% to $1.49. Adjusted EBITDA was $53.4 million with an 11.2% margin, as growth in commercial and international government work offset a 9.5% decline in federal revenue. A lower 17.8% tax rate also supported earnings growth. ICF reaffirmed its 2026 revenue and EPS guidance, while a $9.3 billion pipeline and 1.09 trailing book-to-bill ratio contrasted with delayed federal procurement decisions during the quarter.
TradingKey
Thu, Aug 6
Cryoport Q2 2026 earnings: Services growth brings adjusted EBITDA above zero
Cryoport’s Q2 2026 revenue rose 8% year over year to $49.0 million, led by 15% growth in Life Sciences Services, while Life Sciences Products revenue was essentially flat at $21.0 million. Adjusted EBITDA from continuing operations improved to positive $0.4 million from negative $0.9 million, but the company still recorded a $0.20 diluted loss per share. Overall gross margin edged down to 46.6%, as better services margins were offset by weaker products margins. Cryoport ended the quarter with $396.7 million in cash, cash equivalents and short-term investments.
TradingKey
Thu, Aug 6
The RealReal Q2 2026 Earnings: GMV Growth Expands Adjusted EBITDA Margin
The RealReal’s Q2 2026 revenue rose 17% to $192.6 million as GMV increased 22% to a record $617.3 million. Adjusted EBITDA nearly doubled to $13.5 million, lifting the margin to 7.0% from 4.1%, while gross margin reached 74.4%. GAAP net loss widened to $27.2 million because of an $18.6 million non-cash warrant-liability remeasurement. Q2 free cash flow remained negative at $6.1 million, though it improved from a $15.0 million outflow. The company also raised its full-year GMV and adjusted EBITDA guidance.
TradingKey
Thu, Aug 6
Citizens Q2 2026 Earnings: Premium Growth Could Not Offset Reserve Pressure
Citizens, Inc. reported Q2 2026 revenue of $60.4 million, down from $65.1 million a year earlier, as investment-related results weakened despite higher insurance premiums. Diluted EPS swung to a $0.01 loss from $0.13 of income, while adjusted net income fell to $0.8 million from $4.2 million. Direct insurance premiums rose to $48.1 million, but higher future policy benefit reserves—primarily tied to Domestic Insurance growth and a tougher comparison with prior-year reserve releases—more than offset lower claims and surrenders. Operating cash flow remained positive at $1.7 million.TradingKey
Thu, Aug 6
IBC Q2 2026 Earnings: Net Income and EPS Fall 4.3%
IBC’s Q2 2026 earnings showed net income of $95.8 million and diluted EPS of $1.54, both down 4.3% from a year earlier. For the first six months, net income edged up 0.5% to $198.0 million as interest earned on larger loan and investment portfolios and lower deposit interest expense supported results. Net loans reached about $9.7 billion at June 30, up from $9.3 billion at year-end, while higher credit-loss provisions linked to loan growth and non-accrual balances offset part of the benefit.
TradingKey
Thu, Aug 6
WFCF Q2 2026 Earnings: Margin Expansion Lifted Operating Income
Where Food Comes From (WFCF) reported Q2 2026 revenue of $6.611 million, up 1% year over year, while diluted EPS fell to $0.08 from $0.11. Gross margin expanded to 40.6% from 37.5%, helping operating income rise 21% to $665,000. However, a $240,000 unfavorable swing in the fair value of digital assets reduced net income to $413,000. Verification revenue edged higher, product sales declined, and management said RaiseWell enrollment and non-beef certification programs helped offset pressure from high beef prices and smaller herd sizes.
TradingKey
Thu, Aug 6
Sonoma FY2027 Q1 earnings: 60% revenue growth moves EBITDA positive
Sonoma Pharmaceuticals reported fiscal Q1 2027 revenue of $6.4 million, up 60% year over year, while U.S. revenue increased 141%. Gross profit reached $2.6 million and gross margin expanded to 40% from 36%. With operating expenses unchanged at $2.6 million, the net loss narrowed to $0.3 million from $1.2 million, and company-reported EBITDA improved to a $0.1 million gain. The quarter also included an FDA 510(k) clearance for Microdacyn and new distributors in Taiwan, Vietnam, and the United States.
TradingKey
Thu, Aug 6
Loar Q2 2026 Earnings: Revenue Rises 39% as Adjusted EBITDA Margin Expands
Loar Holdings’ Q2 2026 earnings showed net sales of $171.6 million, up 39.4% year over year, while organic sales rose 12.3%. Adjusted EBITDA increased 47.4% to $69.4 million and its margin expanded to 40.5% from 38.3%. GAAP net income remained flat at $16.7 million as higher interest expense and acquired-intangible amortization offset operating gains, highlighting the gap between acquisition-supported growth, adjusted profitability, and bottom-line earnings.
TradingKey
Thu, Aug 6
MarketWise Q2 2026 Earnings: Billings Rise 57% as GAAP Revenue Falls
MarketWise reported Q2 2026 total net revenue of $75.8 million, down 5.2% year over year, and a diluted loss of $0.24 per share versus earnings of $0.53 a year earlier. Billings rose 56.7% to $91.2 million, while operating cash flow increased 25.7% to $22.4 million. Higher customer acquisition and retention supported current sales, but deferred revenue timing and increased marketing spending produced a $2.6 million net loss. The company raised full-year billings guidance by 10% to approximately $330 million.
TradingKey
Thu, Aug 6
Liberty Capital Q2 2026 Earnings: Flat Revenue, Lower Operating Margins
Liberty Capital reported Q2 2026 revenue of $261 million, flat year over year, while operating income fell 43% to $29 million and Adjusted OIBDA declined 11% to $96 million. Consumer margins benefited from lower video programming costs after the 2025 exit, but higher business distribution and circuit costs drove a sharp decline in consolidated profitability. The company also entered the second half with heavier capital spending, higher leverage tied partly to Quintillion financing, and plans to begin a recurring quarterly dividend in December 2026, subject to board declaration.
TradingKey
Thu, Aug 6
Praxis Q2 2026 results: $1.4 billion liquidity supports runway into 2028
Praxis Precision Medicines’ Q2 2026 results showed a net loss of $83.7 million, up from $71.1 million a year earlier, while diluted loss per share narrowed to $2.87 from $3.31 because the weighted-average share count increased. R&D expense rose to $69.4 million and G&A expense more than doubled to $27.5 million. Cash, cash equivalents and marketable securities totaled approximately $1.4 billion at June 30, supporting operations into 2028 as Praxis prepares for regulatory decisions on relutrigine and ulixacaltamide and advances key epilepsy studies.
TradingKey
Thu, Aug 6
CRA Fiscal Q2 2026 Earnings: Revenue Rises 12.8% as Guidance Increases
Charles River Associates (CRA) reported fiscal Q2 2026 revenue of $210.8 million, up 12.8% year over year, while diluted EPS increased 17.3% to $2.10. Non-GAAP EBITDA rose 15.3% to $26.8 million, with margin improving to 12.7%, supported by broad practice, service-line and geographic growth. CRA raised its constant-currency full-year revenue guidance to $805 million-$820 million and maintained a 12.0%-13.0% non-GAAP EBITDA margin outlook. Investors should also monitor higher service costs, negative first-half operating cash flow and increased borrowing.
TradingKey
Thu, Aug 6
Acorn Energy Q2 2026 Earnings: Recurring Revenue Mix Lifts Gross Margin
Acorn Energy’s Q2 2026 revenue fell 29.4% year over year to $2.489 million, and diluted EPS declined to $0.12 from $0.28 as hardware sales dropped 51.7%. Recurring monitoring revenue rose 8.0% to $1.425 million, shifting the mix toward higher-margin services and lifting gross margin by 750 basis points to 82.4%. The quarter highlights both the resilience of monitoring revenue and the earnings sensitivity to large hardware deployments, while the Champion partnership and OMNI360 launch provide future growth avenues without quantified near-term revenue visibility.TradingKey
Thu, Aug 6
Featured Tools
Top News
Meta Q3 Net Profit Surges 264% YoY, Raises Full-Year Capex Slightly; Shares Briefly Rise Over 4% After Hours
US Stocks Close: Nasdaq Drops 2.6%, SOX Falls Over 6%; Jensen Huang's Remarks on Capital Shortage Spark Financing Concerns, Meta Drops 7% After Earnings
US Stocks Close: Nasdaq Gains Over 1%, Philadelphia Semiconductor Index Rises Nearly 2%; Tech Stocks Strengthen, SpaceX Gains Nearly 8% Post-Earnings
Memory Stocks Fall Over 4% as Micron Drops Below $900, Risking Another 16% Fall to Retest Lows
Bloom Energy Q3 Revenue Up 138% YoY, EPS Swings to Profit, But Shares Tumble 7% After Hours
